{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:37:06Z","timestamp":1761514626691,"version":"3.40.5"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["PRI"],"published-print":{"date-parts":[[2020,12,30]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Malaria is a deadly disease. It is mostly treated using 4-\naminoquinoline derivatives such as chloroquine etc. because it is well-tolerated, displays\nlow toxicity, and after administration, it is rapidly absorbed. The combination of\n4-aminoquinoline with other classes of antimalarial drugs has been reported to be an\neffective approach for the treatment of malaria. Furthermore, some patents reported\nhybrids 4-aminoquinolines containing ferrocene moiety with potent antimalarial activity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The objective of the current study is to prepare 4-aminoquinoline-ferrocene\nhybrids via esterification and amidation reactions. The compounds were characterized via\nFTIR, LC-MS and NMR spectroscopy. In vitro screening against chloroquine-sensitive\nP. falciparum parasite (NF54) at concentrations (1 \u03bcM and 5 \u03bcM) and an inhibitory concentration\n(full dose-response) was studied.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The compounds were prepared via known reactions and monitored by Thin\nLayer Chromatography. The compounds were purified by column chromatography and\ncharacterized using FTIR, NMR and MS. In vitro antiplasmodial evaluation was performed\nagainst asexual parasite and chloroquine was used as a reference drug.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The percentage inhibition effects of the hybrid compounds were in a range of\n97.9-102% at 5 \u03bcM and 36-96% at 1 \u03bcM. Furthermore, the IC50 values of the compounds\nwere in the range of 0.7-1.6 \u03bcM when compared to the parent drug,\n4-ferrocenylketobutanoic acid.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The hybrid compounds displayed significant antimalarial activity when\ncompared to the parent drug. However, they were not as effective as chloroquine on the\ndrug-sensitive parasite. The findings revealed that 4-aminoquinolines and ferrocene are\npotential scaffolds for developing potent antimalarials.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574891x15666200804160322","type":"journal-article","created":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T08:06:02Z","timestamp":1596614762000},"page":"157-172","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["4-Aminoquinoline-ferrocene Hybrids as Potential Antimalarials"],"prefix":"10.2174","volume":"15","author":[{"given":"Xhamla","family":"Nqoro","sequence":"first","affiliation":[{"name":"Department of Chemistry, University of Fort Hare, Alice Campus, Alice, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1157-7481","authenticated-orcid":true,"given":"Blessing A.","family":"Aderibigbe","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Fort Hare, Alice Campus, Alice, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Recent Patents on Anti-Infective Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/184540","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/184540\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/184540","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T05:36:05Z","timestamp":1609479365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/184540\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,30]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,12,30]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574891x15666200804160322","relation":{},"ISSN":["1574-891X"],"issn-type":[{"type":"print","value":"1574-891X"}],"subject":[],"published":{"date-parts":[[2020,12,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-03-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}